Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: Follow-up of a phase 3 study

Neil P. Shah, François Guilhot, Jorge E. Cortes, Charles A. Schiffer, Philipp Le Coutre, Tim H. Brümmendorf, Hagop M. Kantarjian, Andreas Hochhaus, Philippe Rousselot, Hesham Mohamed, Diane Healey, Michael Cunningham, Giuseppe Saglio